Trial Information

Summary: A multi-center, open-labeled study of the safety, efficacy, and pharmacokinetics of lupiprostone in pediatric patients with constipation.

The purpose of this is to see if lubiprostone is safe and effective for use in children. If your child takes part, your child will be one of 120 subjects in the study. This study will involve six study visits including five office visits and one telephone call. Your child’s total participation in the study will last about 8 weeks.

Study inclusion / exclusion criteria

• 17 years of age or younger
• Weighs at least 26 1/2 pounds (12 kg) and is capable of swallowing capsules
• Has been diagnosed with constipation

For more information,

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:30:09 AM